Dipeptidyl peptidase 9
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 4 PDB declaration: tetrameric(4) Consistent with protein copy count | Chain A; UniProt 1–863 Chain D; UniProt 1–863 | Not recorded | Caspase recruitment domain-containing protein 8 × 2 (Q9Y2G2) GK2 [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid × 2 | ELECTRON MICROSCOPY cryo-EM buffer:pH 7.5;25 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM TCEP cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 3.30 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 7JN7 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 6EOQ DPP9 - Apo Deposited 2017-10-10 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–863(863 aa)
Chain C
1–863(863 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;10%PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Caodilate pH6.25,
|
Resolution 3.00 Å R-free 0.334 |
| 6EOQ DPP9 - Apo Deposited 2017-10-10 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;10%PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Caodilate pH6.25,
|
Resolution 3.00 Å R-free 0.334 |
| 6EOR DPP9 - 1G244 Deposited 2017-10-10 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–863(863 aa)
Chain B
1–863(863 aa)
|
Not recorded | 9XH (2~{S})-2-azanyl-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;10% PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Cacodilate pH 6.25
|
Resolution 2.90 Å R-free 0.332 |
| 6EOR DPP9 - 1G244 Deposited 2017-10-10 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | 9XH (2~{S})-2-azanyl-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl)butane-1,4-dione × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;10% PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Cacodilate pH 6.25
|
Resolution 2.90 Å R-free 0.332 |
| 6QZV DPP9 bound to a dipeptide (MP) from the N-terminus of BRCA2 Deposited 2019-03-12 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–892(892 aa)
Chain B
1–892(892 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;20 mg/ml of protein, 10% PEG 8000, 25% glycerol, 0.16 M calcium acetate, 0.08 M cacodilate pH 6.25. Drops are set in a 1:1 ratio.
|
Resolution 3.00 Å R-free 0.345 |
| 6QZV DPP9 bound to a dipeptide (MP) from the N-terminus of BRCA2 Deposited 2019-03-12 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
1–892(892 aa)
Chain D
1–892(892 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;20 mg/ml of protein, 10% PEG 8000, 25% glycerol, 0.16 M calcium acetate, 0.08 M cacodilate pH 6.25. Drops are set in a 1:1 ratio.
|
Resolution 3.00 Å R-free 0.345 |
| 6X6A Cryo-EM structure of NLRP1-DPP9 complex Deposited 2020-05-27 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25 mM Tris pH 7.5, 150 mM NaCl, 1 mM TCEP
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 6X6C Cryo-EM structure of NLRP1-DPP9-VbP complex Deposited 2020-05-27 | Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | GK2 [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid × 2 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25 mM Tris pH 7.5, 150 mM NaCl, 1 mM TCEP
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 7A3F Crystal structure of apo DPP9 Deposited 2020-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–892(892 aa)
Chain B
1–892(892 aa)
|
Not recorded | PO4 PHOSPHATE ION × 2 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.08 M Na-Cacodilate pH 5.25, 0.16 M Ca-Acetate, 30 % Glycerol, 10 % PEG 8K
|
Resolution 2.90 Å R-free 0.290 |
| 7A3F Crystal structure of apo DPP9 Deposited 2020-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–892(892 aa)
Chain D
1–892(892 aa)
|
Not recorded | PO4 PHOSPHATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.08 M Na-Cacodilate pH 5.25, 0.16 M Ca-Acetate, 30 % Glycerol, 10 % PEG 8K
|
Resolution 2.90 Å R-free 0.290 |
| 7JKQ Human DPP9-CARD8 complex Deposited 2020-07-28 | Different ligand/ion Different experimental conditions | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25mM HEPES, pH 7.5, 150 mM NaCl, 1 mM TCEP
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 7SVL DPP9 IN COMPLEX WITH LIGAND ICeD-2 Deposited 2021-11-19 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–863(863 aa)
Chain B
1–863(863 aa)
|
Not recorded | D06 (2S)-2-amino-1-(1,3-dihydro-2H-isoindol-2-yl)-2-[(1r,4S)-4-(pyrrolidin-1-yl)cyclohexyl]ethan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;10% PEG 8000
25% Glycerol
0.16 M Calcium Acetate
0.08 M Cacodilate pH 6.25
|
Resolution 2.46 Å R-free 0.341 |
| 7SVL DPP9 IN COMPLEX WITH LIGAND ICeD-2 Deposited 2021-11-19 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | D06 (2S)-2-amino-1-(1,3-dihydro-2H-isoindol-2-yl)-2-[(1r,4S)-4-(pyrrolidin-1-yl)cyclohexyl]ethan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;10% PEG 8000
25% Glycerol
0.16 M Calcium Acetate
0.08 M Cacodilate pH 6.25
|
Resolution 2.46 Å R-free 0.341 |
| 7SVN DPP9 IN COMPLEX WITH LIGAND ICeD-1 Deposited 2021-11-19 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–863(863 aa)
Chain B
1–863(863 aa)
|
Not recorded | CW8 (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;10% PEG 8000
25% glycerol
0.16 M calcium acetate
0.08 M cacodilate pH 6.25
|
Resolution 2.78 Å R-free 0.349 |
| 7SVN DPP9 IN COMPLEX WITH LIGAND ICeD-1 Deposited 2021-11-19 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–863(863 aa)
Chain D
1–863(863 aa)
|
Not recorded | CW8 (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;10% PEG 8000
25% glycerol
0.16 M calcium acetate
0.08 M cacodilate pH 6.25
|
Resolution 2.78 Å R-free 0.349 |
| 7ZXS Crystal structure of DPP9 in complex with a 4-oxo-b-lactam based inhibitor, A295 Deposited 2022-05-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
20–863(844 aa)
Fragment:extcolor{red}{>FRAGMENT<}
Chain C
20–863(844 aa)
Fragment:extcolor{red}{>FRAGMENT<}
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | KBO 2-ethyl-2-methanoyl-~{N}-[3-[[4-(quinolin-8-ylmethyl)piperazin-1-yl]methyl]phenyl]butanamide × 2 EDO 1,2-ETHANEDIOL × 17 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;The crystal is grown in a condition containing PEG 2K MME buffered by Tris pH 7
|
Resolution 1.81 Å R-free 0.203 |
| 7ZXS Crystal structure of DPP9 in complex with a 4-oxo-b-lactam based inhibitor, A295 Deposited 2022-05-22 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
20–863(844 aa)
Chain D
20–863(844 aa)
|
Not recorded | KBO 2-ethyl-2-methanoyl-~{N}-[3-[[4-(quinolin-8-ylmethyl)piperazin-1-yl]methyl]phenyl]butanamide × 2 EDO 1,2-ETHANEDIOL × 24 PEG DI(HYDROXYETHYL)ETHER × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;The crystal is grown in a condition containing PEG 2K MME buffered by Tris pH 7
|
Resolution 1.81 Å R-free 0.203 |
| 9GOC Crystal structure of DPP9 Ser730Ala in complex with sulphostin. Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
20–863(844 aa)
Chain B
20–863(844 aa)
|
Not recorded | A1INE Sulphostin × 2 EDO 1,2-ETHANEDIOL × 28 PEG DI(HYDROXYETHYL)ETHER × 2 PG5 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG2000 MME 20% (w/v), 0.1 M Tris pH 6.75
|
Resolution 1.89 Å R-free 0.199 |
| 9GOC Crystal structure of DPP9 Ser730Ala in complex with sulphostin. Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
20–863(844 aa)
Chain D
20–863(844 aa)
|
Not recorded | A1INE Sulphostin × 2 EDO 1,2-ETHANEDIOL × 19 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG2000 MME 20% (w/v), 0.1 M Tris pH 6.75
|
Resolution 1.89 Å R-free 0.199 |
| 9GOD Crystal structure of DPP9 in complex with N-phosphono-(S)-3-aminopiperidine-2-one-based inhibitor Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
20–863(844 aa)
Chain D
20–863(844 aa)
|
Not recorded | A1INH ethoxy-[2-(4-pentylphenyl)sulfanylethyl]phosphinous acid × 2 EDO 1,2-ETHANEDIOL × 12 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;18.0% w/v PEG 2K MME; 0.1 M Tris pH 7.25
|
Resolution 2.49 Å R-free 0.219 |
| 9GOD Crystal structure of DPP9 in complex with N-phosphono-(S)-3-aminopiperidine-2-one-based inhibitor Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
20–863(844 aa)
Chain C
20–863(844 aa)
|
Not recorded | A1INH ethoxy-[2-(4-pentylphenyl)sulfanylethyl]phosphinous acid × 2 EDO 1,2-ETHANEDIOL × 23 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;18.0% w/v PEG 2K MME; 0.1 M Tris pH 7.25
|
Resolution 2.49 Å R-free 0.219 |
| 9GON Crystal structure of DPP9 in complex with sulphostin Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
20–863(844 aa)
Chain B
20–863(844 aa)
|
Not recorded | A1INF azanyl-oxidanylidene-(sulfoamino)phosphanium × 2 PEG DI(HYDROXYETHYL)ETHER × 3 EDO 1,2-ETHANEDIOL × 37 CL CHLORIDE ION × 7 NA SODIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% (w/v) PEG 2000 MME, 0.1M Tris pH 6.75
|
Resolution 1.89 Å R-free 0.206 |
| 9GON Crystal structure of DPP9 in complex with sulphostin Deposited 2024-09-05 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
20–863(844 aa)
Chain D
20–863(844 aa)
|
Not recorded | A1INF azanyl-oxidanylidene-(sulfoamino)phosphanium × 2 PEG DI(HYDROXYETHYL)ETHER × 1 EDO 1,2-ETHANEDIOL × 34 CL CHLORIDE ION × 5 NA SODIUM ION × 3 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% (w/v) PEG 2000 MME, 0.1M Tris pH 6.75
|
Resolution 1.89 Å R-free 0.206 |
13 other PDB entries and 23 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | DPP9_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 29–891; UniProt 1–863 Author chain D; PDBConstruct 29–891; UniProt 1–863 |